Nve Corp SEC Filings

NVE Corporation reported its financial results for the quarter ended December 31, 2025, through a press release furnished as an exhibit. The detailed numbers are not included in this text, but the update covers the company’s operations and financial condition for that quarter.

The company also announced that its Board of Directors approved a quarterly cash dividend of $1.00 per share of common stock. The dividend is payable on February 27, 2026 to shareholders of record as of February 2, 2026, providing a direct cash return to current investors on the record date.

Royce & Associates LP, a New York-based investment adviser, reports beneficial ownership of 261,822 shares of NVE Corporation common stock, representing 5.41% of the class as of 12/31/2025. Royce & Associates has sole voting and dispositive power over these shares.

The securities are held in investment accounts of its clients, including registered funds and other managed accounts, and are treated as owned in the ordinary course of business. Royce & Associates certifies the holdings were not acquired and are not held for the purpose of changing or influencing control of NVE. The firm also notes that it and other Franklin Resources affiliates exercise voting and investment powers independently and that Royce & Associates disclaims any pecuniary interest and group status regarding these shares.

NVE Corporation filed an amendment detailing a new change to its long-standing Supplier Partnering Agreement with Abbott’s subsidiary Pacesetter, Inc. Amendment No. 12, executed on December 12, 2025, extends the term of the agreement through December 31, 2027. NVE continues to supply products to Abbott under this agreement, which has been updated multiple times since its original January 3, 2006 signing.

The latest amendment also provides for increased pricing for 2026 and 2027, indicating that future product sales under the agreement will be at higher contractual prices during those years. The full text of Amendment No. 12 is included as Exhibit 10.6 with this amended report.

NVE Corporation filed its quarterly report, posting Q2 FY2026 revenue of $6,346,992 and net income of $3,310,838, or $0.68 per diluted share. Gross margin was 78% of revenue.

Revenue decreased 6% year over year as contract R&D fell 68%, partially offset by a 1% rise in product sales. Operating expenses declined 7%, and interest income was $484,330. The effective tax rate rose to 20%.

Cash and cash equivalents were $5,107,481, with money market funds and marketable securities totaling $45,226,523 and representing approximately 74% of total assets of $61,490,218. The company paid $1.00 per share in dividends during the quarter and subsequently declared another $1.00 dividend payable November 28, 2025. Shares outstanding were 4,837,166 as of September 30, 2025.

NVE Corporation furnished a press release reporting results for the quarter ended September 30, 2025, and announced a quarterly cash dividend.

The Board approved a $1.00 per share dividend on common stock, payable November 28, 2025 to shareholders of record as of November 3, 2025.

NVE Corp Schedule 13G/A discloses beneficial ownership by two investment advisers. Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 307,607 shares, representing 6.4% of NVE ordinary shares, with 85,467 shares of sole voting power, 218,097 shares of shared voting power, 89,510 shares of sole dispositive power and 218,097 shares of shared dispositive power. Virtus Investment Advisers, LLC reports beneficial ownership of 139,104 shares (2.9%), with 139,104 shares of shared voting and dispositive power. The filing explicitly states Virtus's amounts are included in Kayne Anderson Rudnick's totals.

James W. Bracke, a director of NVE Corp (NVEC), received a non‑qualified stock option for 1,000 shares with an exercise price of $61.72. The option is exercisable on 08/07/2025 and expires on 08/07/2035. After the reported transaction, Mr. Bracke directly beneficially owns 5,000 derivative securities. The filing states the option was granted automatically upon his reelection to the board and lists the derivative security price as $0, indicating no cash paid for the grant.

NVE Corporation reported the results of its annual shareholders meeting where votes were taken to elect five directors, to provide advisory approval of named executive officer compensation, and to ratify the appointment of Boulay PLLP as the company’s independent registered public accounting firm. A total of 4,837,166 shares were entitled to vote and a majority was represented at the meeting.

All five incumbent nominees were elected. Vote tallies were: Terrence W. Glarner 2,986,541 for, 283,523 withheld; Daniel A. Baker 3,185,972 for, 84,092 withheld; Patricia M. Hollister 3,030,813 for, 239,251 withheld; James W. Bracke 3,220,647 for, 49,417 withheld; and Kelly Wei 3,226,298 for, 43,766 withheld. The advisory vote on executive compensation passed with 3,171,573 for, 87,852 against, and 10,637 abstentions. The selection of Boulay PLLP as auditor was ratified with 3,871,548 for, 2,794 against, and 11,171 abstentions; the filing notes that abstentions on that proposal were treated as negative votes.

Patricia M. Hollister, a director of NVE Corp (NVEC), was granted a non-qualified stock option for 1,000 shares on 08/07/2025 with an exercise price of $61.72. The option is exercisable beginning 08/07/2025 and expires on 08/07/2035. The filing reports 9,000 shares beneficially owned following the transaction and lists ownership as direct. The form states the option was granted automatically upon Ms. Hollister's reelection to NVE's board. This disclosure documents a routine director equity award that records the grant mechanics, strike price, exercisability and post-transaction holdings.